% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Blotenberg:275938,
author = {Blotenberg, Iris and Wittström, Felix and Michalowsky,
Bernhard and Platen, Moritz and Wucherer, Diana and Teipel,
Stefan and Hoffmann, Wolfgang and Thyrian, Jochen René},
title = {{M}odifiable risk factors and symptom progression in
dementia over up to 8 years-{R}esults of the {D}elp{H}i-{MV}
trial.},
journal = {Alzheimer's $\&$ dementia / Diagnosis, assessment $\&$
disease monitoring},
volume = {17},
number = {1},
issn = {2352-8729},
address = {Hoboken, NJ},
publisher = {Wiley},
reportid = {DZNE-2025-00160},
pages = {e70050},
year = {2025},
abstract = {This study investigated the association between modifiable
factors and symptom progression in dementia over up to 8
years.Multilevel growth curve models assessed the role of
modifiable risk factors (low education, hearing impairment
and its treatment, depression, physical inactivity, diabetes
and its treatment, smoking, hypertension and its treatment,
obesity, alcohol consumption, social isolation, and visual
impairment) on cognitive and functional trajectories in 353
people with dementia.Higher education was associated with
higher initial cognitive status but faster decline.
Antidiabetic medication was associated with slower cognitive
decline, whereas depression and visual impairment were
linked to low baseline functioning and faster cognitive
decline.Several modifiable risk factors influenced symptom
progression. Education initially had a protective effect,
whereas depressive symptoms were linked to worse symptom
progression. Treatment of comorbidities (diabetes, visual
impairment) could have a positive impact on dementia
symptoms. Modifiable risk factors are promising targets for
tertiary prevention.Modifiable risk factors were associated
with symptom progression in dementia over up to 8 years.More
education was associated with higher initial cognitive
status but faster decline.Depressive symptoms were linked to
less favorable symptom progression.Treatment of
comorbidities (diabetes, visual impairment) may positively
impact the course of symptoms.Modifiable risk factors are
promising targets for tertiary prevention.},
keywords = {Alzheimer Disease (Other) / activities of daily living
(Other) / anti‐diabetic medication (Other) / cognition
(Other) / cognitive decline (Other) / comorbidities (Other)
/ depressive symptoms (Other) / education (Other) /
functional decline (Other) / lifestyle (Other) / medication
(Other) / visual impairment (Other)},
cin = {AG Thyrian / AG Michalowsky / AG Hoffmann / AG Teipel},
ddc = {610},
cid = {I:(DE-2719)1510800 / I:(DE-2719)5000067 /
I:(DE-2719)1510600 / I:(DE-2719)1510100},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39811699},
pmc = {pmc:PMC11730075},
doi = {10.1002/dad2.70050},
url = {https://pub.dzne.de/record/275938},
}